Trabectedin plus pegylated liposomal doxorubicin: the return of a treatment option for ovarian cancer

Author: Clare John  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.9, Iss.12, 2013-12, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content